DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Wanbury Limited — Press Release

NSE 54 min ago·16 Oct 2026, 7:38 am

Wanbury

Wanbury Limited filed a press release with the exchange on Oct 16, 2026, stating that it has made progress on regulatory clearances for its API manufacturing segment and highlighted recent operational milestones.

For investors, regulatory approvals are a key gate‑keeper for expanding the API business, which can broaden the company's product portfolio and improve margins. The mention of new business opportunities suggests potential partnerships or entry into new markets, while operational achievements may point to cost efficiencies or capacity expansions.

Going forward, investors should monitor any detailed disclosures about specific approvals, upcoming contracts, or capacity additions, as well as how the company’s earnings reflect these developments.